Dear Blake F, Zou Judy B, Ali Shehzad, Lorian Carolyn N, Johnston Luke, Sheehan Joanne, Staples Lauren G, Gandy Milena, Fogliati Vincent J, Klein Britt, Titov Nickolai
Macquarie University.
Macquarie University.
Behav Ther. 2015 Mar;46(2):206-17. doi: 10.1016/j.beth.2014.09.007. Epub 2014 Oct 17.
There is preliminary support for internet-delivered cognitive behaviour therapy (iCBT) as a way of improving access to treatment among older adults with anxiety. The aim of this randomized controlled trial (RCT) was to examine the efficacy, long-term outcomes, and cost-effectiveness of an iCBT program for adults over 60 years of age with anxiety. Successful applicants were randomly allocated to either the treatment group (n=35) or the waitlist control group (n=37). The online treatment course was delivered over 8 weeks and provided with brief weekly contact with a clinical psychologist via telephone or secure email. Eighty-four percent of participants completed the iCBT course within the 8 weeks and 90% provided data at posttreatment. Significantly lower scores on measures of anxiety (Cohen's d=1.43; 95% CI: 0.89 - 1.93) and depression (Cohen's d=1.79; 95% CI: 1.21 - 2.32) were found among the treatment group compared to the control group at posttreatment. These lower scores were maintained at 3-month and 12-month follow-up and the treatment group rated the iCBT treatment as acceptable. The treatment group had slightly higher costs ($92.2; 95% CI: $38.7 to $149.2) and Quality-Adjusted Life-Years (QALYs=0.010; 95% CI: 0.003 to 0.018) than the control group at posttreatment and the intervention was found to have a greater than 95% probability of being cost-effective. The results support iCBT as an efficacious and cost-effective treatment option for older adults with symptoms of anxiety.
Australian and New Zealand Clinical Trials Registry: ACTRN12611000929909; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000929909.
有初步证据支持通过互联网提供认知行为疗法(iCBT),作为改善老年焦虑症患者治疗可及性的一种方式。这项随机对照试验(RCT)的目的是检验针对60岁以上焦虑症成年人的iCBT项目的疗效、长期效果和成本效益。成功申请者被随机分配到治疗组(n = 35)或等待名单对照组(n = 37)。在线治疗课程为期8周,并通过电话或安全电子邮件每周与临床心理学家进行简短联系。84%的参与者在8周内完成了iCBT课程,90%的参与者在治疗后提供了数据。与对照组相比,治疗组在治疗后焦虑测量指标(科恩d值 = 1.43;95%置信区间:0.89 - 1.93)和抑郁测量指标(科恩d值 = 1.79;95%置信区间:1.21 - 2.32)上的得分显著更低。这些较低得分在3个月和12个月随访时得以维持,且治疗组对iCBT治疗评价可接受。治疗组在治疗后的成本略高于对照组(92.2美元;95%置信区间:38.7美元至149.2美元),质量调整生命年(QALYs = 0.010;95%置信区间:0.003至0.018)也略高于对照组,并且发现该干预措施具有超过95%的成本效益概率。结果支持iCBT作为老年焦虑症症状患者的一种有效且具有成本效益的治疗选择。
澳大利亚和新西兰临床试验注册中心:ACTRN12611000929909;https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12611000929909 。